Bench-to-bedside review: Mechanisms and management of hyperthermia due to toxicity

Critical Care

Volumn 11, Issue 6, 2007, Pages

  Eyer, Florian ^a   Zilker, Thomas ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ADRENERGIC RECEPTOR STIMULATING AGENT; ALLOPURINOL; AMPHETAMINE; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BROMOCRIPTINE; BUTYROPHENONE DERIVATIVE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; COCAINE; CYPROHEPTADINE; DANTROLENE; DOPAMINE RECEPTOR BLOCKING AGENT; HEPARIN; INHALATION ANESTHETIC AGENT; METHAMPHETAMINE; MINOCYCLINE; MONOAMINE OXIDASE INHIBITOR; MUSCLE RELAXANT AGENT; PENTACHLOROPHENOL; PHENETHYLAMINE DERIVATIVE; PHENOTHIAZINE; PHYSOSTIGMINE; SALICYLIC ACID; SEROTONIN AGONIST; SPASMOLYTIC AGENT; UNINDEXED DRUG; DRUG;

ANTICHOLINERGIC SYNDROME; BRADYCARDIA; CONSERVATIVE TREATMENT; COOLING; CORE TEMPERATURE; DIAPHORESIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG MECHANISM; HUMAN; HYPERMETABOLISM; HYPERTHERMIA; INDUCED HYPOTHERMIA; INTENSIVE CARE UNIT; MALIGNANT HYPERTHERMIA; NEUROLEPTIC MALIGNANT SYNDROME; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REPEATED DRUG DOSE; REVIEW; SEIZURE; SEROTONIN SYNDROME; SIDE EFFECT; TACHYCARDIA; TACHYPNEA; THERMOREGULATION; CHEMICALLY INDUCED DISORDER; DISEASE MANAGEMENT; DRUG EFFECT; FEVER; PHYSIOLOGY;

BODY TEMPERATURE REGULATION; DISEASE MANAGEMENT; FEVER; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 84927589436     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc6177     Document Type: Review

References (64)

1. O'Grady NP Barie PS Bartlett J Bleck T Garvey G Jacobi J Linden P Maki DG Nam M Pasculle W et al. Practice parameters for evaluating new fever in critically ill adult patients. Task Force of the American College of Critical Care Medicine of the Society of Critical Care Medicine in collaboration with the Infectious Disease Society of America Crit Care Med 1998, 26:392-408 10.1097/00003246-199802000-00046 9468180
2. Lowell BB Spiegelman BM Towards a molecular understanding of adaptive thermogenesis Nature 2000, 404:652-660 10766252
3. Charkoudian N Skin blood flow in adult human thermoregulation: How it works, when it does not, and why Mayo Clin Proc 2003, 78:603-612 12744548
4. Mallick BN Jha SK Islam F Presence of alpha-1 adrenoreceptors on thermosensitive neurons in the medial preoptico-anterior hypothalamic area in rats Neuropharmacology 2002, 42:697-705 10.1016/ S0028-3908(02)00016-3 11985828
5. Landsberg L Saville ME Young JB Sympathoadrenal system and regulation of thermogenesis Am J Physiol 1984, 247:E181-189 6380306
6. Rusyniak DE Sprague JE Hyperthermic syndromes induced by toxins Clin Lab Med 2006, 26:165-184 ix 10.1016/j.cll.2006.01.007 16567230
7. Gowing LR Henry-Edwards SM Irvine RJ Ali RL The health effects of ecstasy: A literature review Drug Alcohol Rev 2002, 21:53-63 10.1080/ 09595230220119363 12189005
8. Henry JA Jeffreys KJ Dawling S Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy") Lancet 1992, 340:384-387 10.1016/0140-6736(92)91469-O 1353554
9. Ginsberg MD Busto R Combating hyperthermia in acute stroke: A significant clinical concern Stroke 1998, 29:529-534 9472901
10. LoVecchio F Pizon AF Berrett C Balls A Outcomes after environmental hyperthermia Am J Emerg Med 2007, 25:442-444 17499664 10.1016/ j.ajem.2006.11.026
11. Roberts JR Quattrocchi E Howland MA Severe hyperthermia secondary to intravenous drug abuse Am J Emerg Med 1984, 2:373 6518044 10.1016/ 0735-6757(84)90178-5
12. Gordon NF Duncan JJ Effect of beta-blockers on exercise physiology: implications for exercise training Med Sci Sports Exerc 1991, 23:668-676 1679517
13. Steele TD McCann UD Ricaurte GA 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): Pharmacology and toxicology in animals and humans Addiction 1994, 89:539-551 10.1111/j.1360-0443.1994.tb03330.x 7913850
14. Fernandez F Aguerre S Mormede P Chaouloff F Influences of the corticotropic axis and sympathetic activity on neurochemical consequences of 3,4-methylenedioxymethamphetamine (MDMA) administration in Fischer 344 rats Eur J Neurosci 2002, 16:607-618 10.1046/ j.1460-9568.2002.02110.x 12270036
15. Zhao J Cannon B Nedergaard J alpha1-Adrenergic stimulation potentiates the thermogenic action of beta3-adrenoreceptor-generated cAMP in brown fat cells J Biol Chem 1997, 272:32847-32856 10.1074/jbc.272.52.32847 9407062
16. Hadad E Rav-Acha M Heled Y Epstein Y Moran DS Heat stroke: A review of cooling methods Sports Med 2004, 34:501-511 10.2165/ 00007256-200434080-00002 15248787
17. Chan TC Evans SD Clark RF Drug-induced hyperthermia Crit Care Clin 1997, 13:785-808 9330841 10.1016/S0749-0704(05)70369-9
18. Sprague JE Moze P Caden D Rusyniak DE Holmes C Goldstein DS Mills EM Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model Crit Care Med 2005, 33:1311-1316 10.1097/01.CCM.0000165969.29002.70 15942349
19. Bernheim HA Block LH Atkins E Fever: Pathogenesis, pathophysiology, and purpose Ann Intern Med 1979, 91:261-270 223485
20. Khan M Farver D Recognition, assessment and management of neuroleptic malignant syndrome S D J Med 2000, 53:395-400 11016275
21. Caroff SN Mann SC Neuroleptic malignant syndrome Med Clin North Am 1993, 77:185-202 8093494
22. Rosebush PI Stewart T Mazurek MF The treatment of neuroleptic malignant syndrome. Are dantrolene and bromocriptine useful adjuncts to supportive care? Br J Psychiatry 1991, 159:709-712 1843801
23. Carbone JR The neuroleptic malignant and serotonin syndromes Emerg Med Clin North Am 2000, 18:317-325 x 10.1016/S0733-8627(05)70127-9 10767887
24. Rosebush P Stewart T A prospective analysis of 24 episodes of neuroleptic malignant syndrome Am J Psychiatry 1989, 146:717-725 2567121
25. Ananth J Parameswaran S Gunatilake S Burgoyne K Sidhom T Neuroleptic malignant syndrome and atypical antipsychotic drugs J Clin Psychiatry 2004, 65:464-470 15119907
26. Chan-Tack KM Neuroleptic malignant syndrome due to promethazine South Med J 1999, 92:1017-1018 10548178
27. Rainer C Scheinost NA Lefeber EJ Neuroleptic malignant syndrome. When levodopa withdrawal is the cause Postgrad Med 1991, 89:175-178 2008397
28. Caroff SN Mann SC Neuroleptic malignant syndrome Psychopharmacol Bull 1988, 24:25-29 3290944
29. Gurrera RJ Chang SS Thermoregulatory dysfunction in neuroleptic malignant syndrome Biol Psychiatry 1996, 39:207-212 10.1016/ 0006-3223(95)00137-9 8837982
30. Nisijima K Oyafuso K Shimada T Hosino H Ishiguro T Cerebrospinal fluid monoamine metabolism in a case of neuroleptic malignant syndrome improved by electroconvulsive therapy Biol Psychiatry 1996, 39:383-384 10.1016/0006-3223(95)00389-4 8704073
31. Spivak B Maline DI Vered Y Kozyrev VN Mester R Neduva SA Ravilov RS Graff E Weizman A Prospective evaluation of circulatory levels of catecholamines and serotonin in neuroleptic malignant syndrome Acta Psychiatr Scand 2000, 102:226-230 10.1034/j.1600-0447.2000.102003226.x 11008859
32. Velamoor VR Neuroleptic malignant syndrome. Recognition, prevention and management Drug Saf 1998, 19:73-82 10.2165/00002018-199819010-00006 9673859
33. Hadad E Weinbroum AA Ben-Abraham R Drug-induced hyperthermia and muscle rigidity: A practical approach Eur J Emerg Med 2003, 10:149-154 10.1097/ 00063110-200306000-00018 12789076
34. Adnet P Lestavel P Krivosic-Horber R Neuroleptic malignant syndrome Br J Anaesth 2000, 85:129-135 10.1093/bja/85.1.129 10928001
35. Nierenberg D Disch M Manheimer E Patterson J Ross J Silvestri G Summerhill E Facilitating prompt diagnosis and treatment of the neuroleptic malignant syndrome Clin Pharmacol Ther 1991, 50:580-586 1934871
36. Halloran LL Bernard DW Management of drug-induced hyperthermia Curr Opin Pediatr 2004, 16:211-215 10.1097/00008480-200404000-00018 15021205
37. Dunkley EJ Isbister GK Sibbritt D Dawson AH Whyte IM The Hunter Serotonin Toxicity Criteria: Simple and accurate diagnostic decision rules for serotonin toxicity QJM 2003, 96:635-642 10.1093/qjmed/hcg109 12925718
38. Saper G Brain stem modulation of sensation, movement, and consciousness Principles of Neural Science New York: Mc Graw-Hill Kendel ER, Schwartz JH, Jessel TM 2000, 896
39. Mason PJ Morris VA Balcezak TJ Serotonin syndrome. Presentation of 2 cases and review of the literature Medicine 2000, 79:201-209 10.1097/ 00005792-200007000-00001 10941349
40. Boyer EW Shannon M The serotonin syndrome N Engl J Med 2005, 352:1112-1120 10.1056/NEJMra041867 15784664
41. Mills KC Serotonin syndrome. A clinical update Crit Care Clin 1997, 13:763-783 9330840 10.1016/S0749-0704(05)70368-7
42. Van Oekelen D Megens A Meert T Luyten WH Leysen JE Role of 5-HT(2) receptors in the tryptamine-induced 5-HT syndrome in rats Behav Pharmacol 2002, 13:313-318 12218512
43. Packer S Berman SA Serotonin syndrome precipitated by the monoamine oxidase inhibitor linezolid Am J Psychiatry 2007, 164:346-347 10.1176/ appi.ajp.164.2.346-b 17267801
44. Sampson E Warner JP Serotonin syndrome: Potentially fatal but difficult to recognize Br J Gen Pract 1999, 49:867-868 1313553 10818648
45. Baigel GD Cyproheptadine and the treatment of an unconscious patient with the serotonin syndrome Eur J Anaesthesiol 2003, 20:586-588 10.1017/ S0265021503270927 12884999
46. Mills K Serotonin syndrome Critical Care Toxicology: Diagnosis and Management of the Critically Poisoned Patient Philadelphia: Elsevier Mosby Brent J, Wallace K, Burkhart K, Phillips S, Ward Donovan J 2005, 281-290
47. Gillman PK The serotonin syndrome and its treatment J Psychopharmacol 1999, 13:100-109 10221364
48. Kapur S Zipursky RB Jones C Wilson AA DaSilva JD Houle S Cyproheptadine: a potent in vivo serotonin antagonist Am J Psychiatry 1997, 154:884 9167527
49. Wallace KB Starkov AA Mitochondrial targets of drug toxicity Annu Rev Pharmacol Toxicol 2000, 40:353-388 10.1146/annurev.pharmtox.40.1.353 10836141
50. Farquharson ME Gage JC Northover J The biological action of chlorophenols Br J Pharmacol Chemother 1958, 13:20-24 13523129
51. Gutknecht J Salicylates and proton transport through lipid bilayer membranes: A model for salicylate-induced uncoupling and swelling in mitochondria J Membr Biol 1990, 115:253-260 10.1007/BF01868640 2165171
52. Jorens PG Schepens PJ Human pentachlorophenol poisoning Hum Exp Toxicol 1993, 12:479-495 7904464
53. Robson AM Kissane JM Elvick NH Pundavela L Pentachlorophenol poisoning in a nursery for newborn infants. I. Clinical features and treatment J Pediatr 1969, 75:309-316 10.1016/S0022-3476(69)80406-3 5795352
54. Chapman BJ Proudfoot AT Adult salicylate poisoning: Deaths and outcome in patients with high plasma salicylate concentrations Q J Med 1989, 72:699-707 2602553
55. Denborough M Malignant hyperthermia Lancet 1998, 352:1131-1136 10.1016/ S0140-6736(98)03078-5 9798607
56. Hopkins PM Malignant hyperthermia: Advances in clinical management and diagnosis Br J Anaesth 2000, 85:118-128 10.1093/bja/85.1.118 10928000
57. Wappler F Fiege M Steinfath M Agarwal K Scholz J Singh S Matschke J Schulte Am Esch J Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis Anesthesiology 2001, 94:95-100 10.1097/00000542-200101000-00019 11135728
58. Ward A Chaffman MO Sorkin EM Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity Drugs 1986, 32:130-168 10.2165/ 00003495-198632020-00003 3527659
59. Mackowiak PA LeMaistre CF Drug fever: A critical appraisal of conventional concepts. An analysis of 51 episodes in two Dallas hospitals and 97 episodes reported in the English literature Ann Intern Med 1987, 106:728-733 3565971
60. Johnson DH Cunha BA Drug fever Infect Dis Clin North Am 1996, 10:85-91 10.1016/S0891-5520(05)70287-7 8698996
61. Cunha BA Fever in the critical care unit Crit Care Clin 1998, 14:1-14 9448975 10.1016/S0749-0704(05)70378-X
62. Marik PE Fever in the ICU Chest 2000, 117:855-869 10.1378/ chest.117.3.855 10713016
63. Peres Bota D Melot C Lopes Ferreira F Vincent JL Infection Probability Score (IPS): A method to help assess the probability of infection in critically ill patients Crit Care Med 2003, 31:2579-2584 10.1097/ 01.CCM.0000094223.92746.56 14605527
64. Ryan M Levy MM Clinical review: Fever in intensive care unit patients Crit Care 2003, 7:221-225 270667 12793871 10.1186/cc1879